Wugen

Biotechnology company developing next-generation cell therapies using memory natural killer (NK) cells for the treatment of cancer. Part of the Abingworth portfolio.

Location
St. Louis, Missouri, USA
Founded
2018
Investors
1
Categories
biotech, cell-therapy, oncology, nk-cells

Investors

NameLocationTypeStagesPortfolio
AbingworthLondon, UK / Boston, USAbiotech-focused
seedseries-a+3
34